Multiple Viral Determinants Mediate Myopathogenicity in Coxsackievirus B1-Induced Chronic Inflammatory Myopathy

Journal of Virology

Volumn 77, Issue 21, 2003, Pages 11849-11854

  Tam, Patricia E ^a   Weber Sanders, Melissa L ^a   Messner, Ronald P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP1; PROTEINASE; TYROSINE; VALINE;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CHRONIC INFLAMMATION; CLONE; CONTROLLED STUDY; COXSACKIE VIRUS B; HAMSTRING; HINDLIMB; HISTOPATHOLOGY; MOUSE; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHRONIC DISEASE; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; GENOME, VIRAL; HINDLIMB; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MYOSITIS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 0142028818     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.21.11849-11854.2003     Document Type: Article

References (31)

1. Caggana, M., P. Chan, and A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:4797-4803.
2. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
3. Equestre, M., D. Genovese, F. Cavalieri, L. Fiore, R. Santoro, and R. Perez Bercoff. 1991. Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2. J. Virol. 65:2707-2710.
4. Galbraith, D. N., C. Nairn, and G. B. Clements. 1997. Evidence for enteroviral persistence in humans. J. Gen. Virol. 78:307-312.
5. Goodfellow, I., Y. Chaudhry, A. Richardson, J. Meredith, J. W. Almond, W. Barclay, and D. J. Evans. 2000. Identification of a cis-acting replication element within the poliovirus coding region. J. Virol. 74:4590-4600.
6. Halim, S., and A. I. Ramsingh. 2000. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 269:86-94.
7. Iizuka, N., S. Kuge, and A. Nomoto. 1987. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology 156:64-73.
8. Jakob, J., and R. P. Roos. 1996. Molecular determinants of Theiler's murine encephalomyelitis-induced disease. J. Neurovirol. 2:70-77.
9. Jongen, P. J., F. W. Heessen, H. J. ter Laak, J. M. Galama, and F. J. Gabreels. 1994. Coxsackie B1 virus-induced murine myositis: relationship of disease severity to virus dose and antiviral antibody response. Neuromusc. Disord. 4:17-23.
10. Klingel, K., B. M. McManus, and R. Kandolf. 1995. Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis? Eur. Heart J. 16:42-45.
11. Muckelbauer, J. K., M. Kremer, I. Minor, G. Diana, F. J. Dutko, J. Groarke, D. C. Pevear, and M. G. Rossmann. 1995. The structure of coxsackievirus B3 at 3.5 Å resolution. Structure 3:653-667.
12. Muir, P., and L. C. Archard. 1994. There is evidence for persistent enterovirus infections in chronic medical conditions in humans. Rev. Med. Virol. 4:245-250.
13. Muir, P., F. Nicholson, S. J. Illavia, T. S. McNeil, J. F. Ajetunmobi, H. Dunn, W. G. Starkey, K. N. Reetoo, N. R. Cary, J. Parameshwar, and J. E. Banatvala. 1996. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart 76:243-249.
14. Murray, M. G., J. Bradley, X.-F. Yang, E. Wimmer, E. G. Moss, and V. R. Racaniello. 1988. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 241:213-215.
15. Pallansch, M. A. 1997. Coxsackievirus B epidemiology and public health concerns. Curr. Top. Microbiol. Immunol. 223:13-30.
16. Parker, L. T., H. Zakeri, Q. Deng, S. Spurgeon, P.-Y. Kwok and D. A. Nickerson. 1996. AmpliTaq DNA polymerase, FS dye-terminator sequencing: analysis of peak height patterns. BioTechniques 21:694-699.
17. Ramsingh, A. I., N. Chapman, and S. Tracy. 1997. Coxsackieviruses and diabetes. Bioessays 19:793-800.
18. Ramsingh, A. I., W. T. Lee, D. N. Collins, and L. E. Armstrong. 1997. Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J. Virol. 71:8690-8697.
19. Ray, C. G., L. L. Minnich, and P. C. Johnson. 1979. Selective polymyositis induced by coxsackievirus B1 in mice. J. Infect. Dis. 140:239-243.
20. Reimann, B. Y., R. Zell, and R. Kandolf. 1991. Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera. J. Virol. 65:3475-3480.
21. Ren, R., E. G. Moss, and V. R. Racaniello. 1991. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65:1377-1382.
22. Strongwater, S. L., Z. K. Dorovini, R. D. Ball, and T. J. Schnitzer. 1984. A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain). Arthritis Rheum. 27:433-442.
23. Tam, P. E., D. R. Fontana, and R. P. Messner. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses. J. Lab. Clin. Med. in press.
24. Tam, P. E., and R. P. Messner. 1997. Coxsackievirus-induced chronic inflammatory myopathy: virus variants distinguish between acute cytopathic effects and pathogenesis of chronic disease. Virology 233:199-209.
25. Tam, P. E., and R. P. Messner. 1996. Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effect of host background and major histocompatibility complex genes. J. Lab. Clin. Med. 128:279-289.
26. Tam, P. E., A. M. Schmidt, S. R. Ytterberg, and R. P. Messner. 1994. Duration of virus persistence and its relationship to inflammation during the chronic phase of coxsackievirus B1-induced murine polymyositis. J. Lab. Clin. Med. 123:346-356.
27. Tam, P. E., A. M. Schmidt, S. R. Ytterberg, and R. P. Messner. 1991. Viral persistence during the developmental phase of coxsackievirus B1-induced murine polymyositis. J. Virol. 65:6654-6660.
28. Wiegers, K., H. Uhlig, and R. Dernick. 1989. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. Virology 170:583-586.
29. Yousef, G. E., D. A. Isenberg, and J. F. Mowbray. 1990. Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann. Rheum. Dis. 49:310-315.
30. Ytterberg, S. R., M. L. Mahowald, and R. P. Messner. 1987. Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice. J. Clin. Investig. 80:499-506.
31. Ytterberg, S. R., M. L. Mahowald, and R. P. Messner. 1988. T cells are required for coxsackievirus B1 induced murine polymyositis. J. Rheumatol. 15:475-478.